TREATMENT OF TARDIVE SYNDROMES This is a summary of the American Academy of Neurology (AAN) guideline regarding management of tardive syndromes (TDS), including …

American Academy of Neurology (AAN) The American Academy of Neurology (AAN) guidelines for the treatment of tardive dyskinesia (TD) provide evidence-based recommendations for the …

Tardive dyskinesia is a movement disorder characterised by irregular, stereotyped, and choreiform movements associated with the use of antipsychotic medication. We aim to provide …

This guideline provides evidence-based recommendations for the treatment of tardive syndromes, focusing on effective management strategies and therapeutic interventions.

Tardive dyskinesia (TD) is a medication-induced hyperkinetic movement disorder associated with the use of dopamine receptor-blocking agents, including first- and second-generation …

TD, tardive dyskinesia; VMAT2, vesicular monoamine transporter 2. * Level A is the strongest recommendation, established as effective, based on at least 2 consistent class I studies. Level …

TD Treatment The Recommended Treatment Guidelines The 2020 American Psychological Association (APA) Practice Guideline recommends that patients with moderate-to-severe or …

Background: Management of tardive syndromes (TS) is challenging, with only a few evidence-based therapeutic algorithms reported in the American Academy of Neurology (AAN) guideline …

Tardive Dyskinesia Treatment Guidelines: An Overview Tardive dyskinesia (TD) is a neurologic disorder involving involuntary, repetitive body movements that often result from long-term use …

TDS includes not only lingual-facial-buccal dyskinesia but also the variant forms, collectively termed tardive syndromes. 2 – 8 In this guideline, tardive dyskinesia encompasses all forms of …